Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.4300
-0.0070 (-1.60%)
Sep 2, 2026, 4:39 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 125.52 million as of September 2, 2026. Its market cap has decreased by -29.42% in one year.
Market Cap
125.52M
Enterprise Value
59.41M
Revenue
13.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.43
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 125.52M, a decrease of -40.23%. That is a compound annual growth rate of -5.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 125.52M | 16.22% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 182.19M |
| Abera Bioscience AB | 163.17M |
| Alzinova AB | 162.11M |
| Initiator Pharma | 160.18M |
| Diamyd Medical AB | 158.70M |
| Xintela AB | 142.11M |
| Active Biotech AB | 134.97M |
| Simris Group AB (PUBL) | 134.17M |